Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Fibrodysplasia Ossificans Progressiva
1.000 Biomarker disease GENOMICS_ENGLAND
Fibrodysplasia Ossificans Progressiva
1.000 CausalMutation disease CLINVAR
Fibrodysplasia Ossificans Progressiva
1.000 Biomarker disease CTD_human
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva. 17077940 2006
Fibrodysplasia Ossificans Progressiva
1.000 AlteredExpression disease BEFREE Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP. 16642017 2006
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease UNIPROT Protein modeling predicts destabilization of the GS domain, consistent with constitutive activation of ACVR1 as the underlying cause of the ectopic chondrogenesis, osteogenesis and joint fusions seen in FOP. 16642017 2006
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE Here, we examined three Japanese patients with FOP for ACVR1 mutations. 17351709 2007
Fibrodysplasia Ossificans Progressiva
1.000 AlteredExpression disease BEFREE Protein modeling predicts that substitution with histidine, and only histidine, creates a pH-sensitive switch within the activation domain of the receptor that leads to ligand-independent activation of ACVR1 in fibrodysplasia ossificans progressiva. 17572636 2007
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE The discovery of the FOP gene establishes a critical milestone in understanding FOP, reveals a highly conserved druggable target in the TGF-beta/bone morphogenetic protein signaling pathway and compels therapeutic approaches for the development of small molecule signal transduction inhibitors for activin-like kinase-2. 17477807 2007
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE We report here on a 62-year-old man with slowly progressive FOP and a novel mutation in ACVR1. 18203193 2008
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE A unique mutation of ALK2, G356D, found in a patient with fibrodysplasia ossificans progressiva is a moderately activated BMP type I receptor. 18952055 2008
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE FOP has been shown to result from a point mutation (c.617G>A) in the ACVR1 gene in almost all patients reported. 19330033 2009
Fibrodysplasia Ossificans Progressiva
1.000 Biomarker disease GENOMICS_ENGLAND The identification of ACVR1 as the causative gene for FOP now allows the genetic screening of FOP patients to identify the frequency of the identified recurrent ACVR1 mutation and to investigate genetic variability that may be associated with this severely debilitating disease. 18830232 2009
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE While the recurrent c.617G>A; p.R206H mutation was found in all cases of classic FOP and most cases of FOP-plus, novel ACVR1 mutations occur in the FOP variants and two cases of FOP-plus. 19085907 2009
Fibrodysplasia Ossificans Progressiva
1.000 Biomarker disease BEFREE The identification of ACVR1 as the causative gene for FOP now allows the genetic screening of FOP patients to identify the frequency of the identified recurrent ACVR1 mutation and to investigate genetic variability that may be associated with this severely debilitating disease. 18830232 2009
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease UNIPROT While the recurrent c.617G>A; p.R206H mutation was found in all cases of classic FOP and most cases of FOP-plus, novel ACVR1 mutations occur in the FOP variants and two cases of FOP-plus. 19085907 2009
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease UNIPROT FOP has been shown to result from a point mutation (c.617G>A) in the ACVR1 gene in almost all patients reported. 19330033 2009
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE Gene transfer of Smad7 or inhibition of type I receptors with dorsomorphin may represent strategies for blocking the activity induced by ALK2(R206H) in FOP. 18684712 2009
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease CLINVAR While the recurrent c.617G>A; p.R206H mutation was found in all cases of classic FOP and most cases of FOP-plus, novel ACVR1 mutations occur in the FOP variants and two cases of FOP-plus. 19085907 2009
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE ACVR1 gene mutation in sporadic Korean patients with fibrodysplasia ossificans progressiva. 19543505 2009
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE This study aimed to investigate the ACVR1 gene mutation in Chinese FOP patients. 19300893 2009
Fibrodysplasia Ossificans Progressiva
1.000 Biomarker disease BEFREE Compared with control cells FOP-ALK2-expressing cells induced increased bone formation. 19929436 2010
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. 19795179 2010
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE In lesions from individuals with fibrodysplasia ossificans progressiva (FOP), a disease in which heterotopic ossification occurs as a result of activating ALK2 mutations, or from transgenic mice expressing constitutively active ALK2, chondrocytes and osteoblasts expressed endothelial markers. 21102460 2010
Fibrodysplasia Ossificans Progressiva
1.000 GeneticVariation disease BEFREE Our study contributes to the understanding of the predominant FOP phenotype and genotype and suggests that variant FOP phenotypes are associated with specific mutations in ACVR1 gene. 19796185 2010